UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93

PloS one, 2014-01, Vol.9 (1), p.e83884-e83884

2014

Volltextzugriff (PDF)

Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy

Vaccine, 2015-11, Vol.33 (48), p.6570-6578

2015

Volltextzugriff (PDF)

Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach

Journal of controlled release, 2016-12, Vol.244 (Pt A), p.98-107

2016

Volltextzugriff (PDF)

Assessment of Antigen-Specific Cellular Immunogenicity Using Intracellular Cytokine Staining, ELISpot, and Culture Supernatants

Methods in molecular biology (Clifton, N.J.), 2017-01, Vol.1494, p.313

2017

Volltextzugriff (PDF)

Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate

Clinical and vaccine immunology, 2016-02, Vol.23 (2), p.137-147

2016

Volltextzugriff (PDF)

Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism

The Journal of immunology (1950), 2015-10, Vol.195 (7), p.3190-3197

2015

Volltextzugriff (PDF)

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach

International journal of nanomedicine, 2018-01, Vol.13, p.3689-3711

2018

Volltextzugriff (PDF)

Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4⁺ T-Cell Responses for Vaccine Control of Tuberculosis

The Journal of infectious diseases, 2015-08, Vol.212 (3), p.495-504

2015

Volltextzugriff (PDF)

Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis

The Journal of immunology (1950), 2014-09, Vol.193 (6), p.2911-2918

2014

Volltextzugriff (PDF)

Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization

Journal of controlled release, 2014-03, Vol.177, p.20-26

2014

Volltextzugriff (PDF)

Increased protection and decreased lung immunopathology induced by the ID93/GLA-SE vaccine candidate following infection with Mycobacterium tuberculosis HN878

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.76-76.20

2016

Volltextzugriff (PDF)

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93: e83884

PloS one, 2014-01, Vol.9 (1)

2014

Volltextzugriff (PDF)

Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology

npj vaccines, 2019-01, Vol.4 (1), p.1-1, Article 1

2019

Volltextzugriff (PDF)

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model

PloS one, 2021-03, Vol.16 (3), p.e0247990-e0247990

2021

Volltextzugriff (PDF)

Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen

Vaccine, 2016-04, Vol.34 (19), p.2207-2215

2016

Volltextzugriff (PDF)

SOI Poly-defined Diode for ESD Protection in High Speed I/Os

2006 IEEE International Reliability Physics Symposium Proceedings, 2006, p.635-636

2006

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)
Tagungsberichte
(1)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Animals
(11)
Life Sciences & Biomedicine
(11)
Immunology
(8)
Mice
(8)
Mycobacterium Tuberculosis
(8)
Infectious Diseases
(7)
Mice, Inbred C57bl
(7)
Tuberculosis Vaccines - Immunology
(7)
Antigens
(6)
Mycobacterium Tuberculosis - Immunology
(6)
Vaccines
(6)
Cd4-Positive T-Lymphocytes - Immunology
(5)
Female
(5)
Th1 Cells - Immunology
(5)
Tuberculosis - Immunology
(5)
Immunity, Cellular
(4)
Proteins
(4)
Tuberculosis
(4)
Tuberculosis - Prevention & Control
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93

Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy

Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach

Assessment of Antigen-Specific Cellular Immunogenicity Using Intracellular Cytokine Staining, ELISpot, and Culture Supernatants

Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate

Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach

Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4⁺ T-Cell Responses for Vaccine Control of Tuberculosis

Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis

Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization

Increased protection and decreased lung immunopathology induced by the ID93/GLA-SE vaccine candidate following infection with Mycobacterium tuberculosis HN878

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93: e83884

Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model

Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen

SOI Poly-defined Diode for ESD Protection in High Speed I/Os

Suchergebnisse filtern